From bench to bedside for gene-directed enzyme prodrug therapy of cancer
作者： Gabi U. Dachs , Joanna Tupper , Gillian M. Tozer
DOI: 10.1097/00001813-200504000-00001
关键词:
摘要: Gene therapy of cancer offers the possibility a targeted treatment that destroys tumors and metastases, but not normal tissues. In gene-directed enzyme prodrug (GDEPT), or suicide gene therapy, encoding an is delivered to tumor cells, followed by administration prodru
sci-hub.se 参考文章(100)
Hsu H, Eling Dj, Spear Ma, Sakamoto Km, Quinones A, Rainov Ng, Combined radiation and cytochrome CYP4B1/4-ipomeanol gene therapy using the EGR1 promoter. Anticancer Research. ,vol. 23, pp. 2723- 2728 ,(2003)
Katsuji KOBORI, Hirokazu SAKAKIBARA, Katsuya MARUYAMA, Toshiji KOBAYASHI, Toshio YAMAKI, [A rapid method for determining urinary indoleacetic acid concentration and its clinical significance as the tumor-marker in the diagnosis of malignant diseases]. Journal of UOEH. ,vol. 5, pp. 213- 220 ,(1983) , 10.7888/JUOEH.5.213
C Cunningham, J Nemunaitis, A phase I trial of genetically modified Salmonella typhimurium expressing cytosine deaminase (TAPET-CD, VNP20029) administered by intratumoral injection in combination with 5-fluorocytosine for patients with advanced or metastatic cancer. Protocol no: CL-017. Version: April 9, 2001. Human Gene Therapy. ,vol. 12, pp. 1594- 1596 ,(2001)
Gillian M. Anlezark, Roger G. Melton, Roger F. Sherwood, Brian Coles, Frank Friedlos, Richard J. Knox, The bioactivation of 5-(aziridin-1-yl)-2,4-dinitrobenzamide (CB1954)--I. Purification and properties of a nitroreductase enzyme from Escherichia coli--a potential enzyme for antibody-directed enzyme prodrug therapy (ADEPT). Biochemical Pharmacology. ,vol. 44, pp. 2289- 2295 ,(1992) , 10.1016/0006-2952(92)90671-5
M P Saunders, A V Patterson, E C Chinje, A L Harris, I J Stratford, NADPH:cytochrome c (P450) reductase activates tirapazamine (SR4233) to restore hypoxic and oxic cytotoxicity in an aerobic resistant derivative of the A549 lung cancer cell line British Journal of Cancer. ,vol. 82, pp. 651- 656 ,(2000) , 10.1054/BJOC.1999.0977
Savio L C Woo, Mary R. Schwartz, Shu Hsia Chen, Bert W. O'Malley, Adenovirus-mediated Gene Therapy for Human Head and Neck Squamous Cell Cancer in a Nude Mouse Model Cancer Research. ,vol. 55, pp. 1080- 1085 ,(1995)
Nghe Nguyen-Ba, Antiviral nucleoside analogues ,(1999)
Guy Chung-Faye, Syed Hussain, Peter Searle, Philip I. Murray, David Anderson, Joanna Baddeley, David Ferry, Daniel Palmer, Joanna Clark, Peter A. Harris, David J. Kerr, Mandy Downes, Leonard Seymour, Virus-directed, enzyme prodrug therapy with nitroimidazole reductase: a phase I and pharmacokinetic study of its prodrug, CB1954. Clinical Cancer Research. ,vol. 7, pp. 2662- 2668 ,(2001)
Donald W. Kufe, David J. Waxman, Dongshu Chen, Ling Chen, Sensitization of Human Breast Cancer Cells to Cyclophosphamide and Ifosfamide by Transfer of a Liver Cytochrome P450 Gene Cancer Research. ,vol. 56, pp. 1331- 1340 ,(1996)
Seppo A I Yla-Herttuala, Anu-Maaria Sandmair, Sami A I Loimas, Matti Vapalahti, Adenovirus-mediated gene therapy ,(1999)